Lv4
438 积分 2023-08-02 加入
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
11天前
已完结
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
13天前
已完结
CD300ld on neutrophils is required for tumour-driven immune suppression
23天前
已完结
MOR202, a Human Anti-CD38 Monoclonal Antibody, Mediates Potent Tumoricidal Activity In Vivo and Shows Synergistic Efficacy in Combination with Different Antineoplastic Compounds
29天前
已关闭
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
29天前
已完结
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair
1个月前
已完结
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B‐cell lineage neoplasms
1个月前
已完结
TSLP acts on regulatory T cells to maintain their identity and limit allergic inflammation
1个月前
已完结
Homeostatic maturation programs drive human cDC2s into a tolerogenic state
1个月前
已完结
Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy
1个月前
已完结
皖公网安备34019202002308
